r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders
- PMID: 9935339
- DOI: 10.1002/hep.510290135
r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders
Comment on
-
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.Hepatology. 1998 Aug;28(2):341-6. doi: 10.1002/hep.510280208. Hepatology. 1998. PMID: 9695995 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources